Evaluation of Amino Acid Infusion preventive effect on Hypothermia during Spinal Anesthesia for Hip Arthroplasty

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170429033680N5

Enrollment

Registered

2018-01-30

Start date

2012-09-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Anesthesia. Conversion disorder with sensory symptom or deficit

Interventions

Intervention 1: Intervention group: The amino acid(10%) of an hour before anesthesia starts at 240 kJ / hr and continue until the end of surgery. Intervention 2: Control group: Ringer Serum Injection.

Prevention

Placebo

Intervention group: The amino acid(10%) of an hour before anesthesia starts at 240 kJ / hr and continue until the end of surgery.

Control group: Ringer Serum Injection

Eligibility

Sex/Gender

All

Age

16 Years to 70 Years

Inclusion criteria

Inclusion criteria: Candidated to hip arthroplasty Undergoing spinal anesthesia

Exclusion criteria

Exclusion criteria: Primary coagulation disorder Diabetic Secondary hip arthroplasty consuming of NSAIDS drugs sensitive to amino acids Consuming Atropin before surgery

Design outcomes

Primary

Measure	Time frame
Heart rate. Timepoint: during surgery. Method of measurement: Using an electrocardiogram or ECG device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Rajaei

Mashhad University of Medical Sciences

rajaeim931@mums.ac.ir+98 518022711

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026